Results 11 to 20 of about 5,486,230 (294)

Investigating the impact of NHS based ovarian cancer screening [PDF]

, 2010
the UK ovarian cancer is the fifth most common cancer in females and after uterine cancer, the second most common gynaecological cancer. There were 6,596 new cases diagnosed in the UK in 2006.
Nicholson, S. M.
core   +6 more sources

The effects of anti-IL-6 therapy in advanced ovarian cancer [PDF]

, 2010
PhDIL-6 is a pleiotropic cytokine that has a significant role in inflammatory processes. In relation to ovarian cancer biology there is emerging evidence that it mediates processes relating to tumour growth, invasion, angiogenesis and chemo-resistance ...
Coward, Jermaine
core   +4 more sources

Differential expression of mTOR signalling components in drug resistance in ovarian cancer [PDF]

, 2010
This article has been made available through the Brunel Open Access Publishing Fund and is available from the specified link - Copyright @ 2010 The International Institute of Anticancer Research.Background/Aim: A limitation to successful cancer ...
Karteris, E, Foster, H, Goumenou, A, Pados, G, Harvey, AJ, Coley, HM   +5 more
core   +5 more sources

Ovarian Cancer: Latest Advances and Prospects [PDF]

Journal of Clinical Medicine, 2021
The landscape of ovarian cancer therapeutics is experiencing an increase in new opportunities [...]
Dion, Ludivine, Lavoué, Vincent
openaire   +3 more sources

Targeted anti-vascular therapies for ovarian cancer: current evidence [PDF]

, 2013
Ovarian cancer presents at advanced stage in around 75% of women, and despite improvements in treatments such as chemotherapy, the 5-year survival from the disease in women diagnosed between 1996 and 1999 in England and Wales was only 36%.
Mcneish, I., Gore, M., M Hall, Gore, M, C Gourley, Hall, M, Kaye, S, Gourley, C., Ledermann, J, McNeish, I, Jayson, G.; id_orcid, Gourley, C, G Jayson, Jayson, G., Kaye, S., Rustin, G, M Gore, J Ledermann, S Kaye, Perren, T, I McNeish, Hall, M., G Rustin, Rustin, G., Perren, T., T Perren, Jayson, G, Ledermann, J.   +27 more
core   +1 more source

Efficacy and safety of olaparib in advanced ovarian cancer: a meta-analysis

Journal of Obstetrics and Gynaecology, 2023
This study aimed to evaluate the efficacy and safety of olaparib for the treatment of advanced ovarian cancer. All studies that assessed the efficacy and safety of olaparib in advanced ovarian cancer were searched in PubMed, Embase, and Web of Science ...
Yuanyuan Yang, Xiaoyun Yang, Huaifang Li, Xiaowen Tong, Xinxian Zhu   +4 more
doaj   +1 more source

Advances in epithelial ovarian cancer

Australian Journal of General Practice, 2020
Most epithelial ovarian cancer occurs in older women, with a mean age at diagnosis of 62 years and an overall five‑year survival rate in Australia of 43%. Most women are diagnosed with advanced disease of high-grade serous type with 20-30% five-year survival; 70% relapse within three years of initial treatment.
Deborah, Neesham, Anthony, Richards, Melissa, McGauran   +2 more
openaire   +3 more sources

Psychological distress and its correlates in ovarian cancer: a systematic review [PDF]

, 2008
Objective: Ovarian cancer is often diagnosed at an advanced stage, and consequently high levels of distress are often experienced. It is necessary to understand the factors associated with psychological distress in order to guide interventions to target ...
Gidron, Y., Arden-Close, Emily, Emily Arden‐Close, Moss-Morris, Rona, Rona Moss‐Morris, Yori Gidron, Moss-Morris, R., Gidron, Yori, Moss-Morris, Rona; id_orcid   +8 more
core   +1 more source

Patients' and oncologists' views on the treatment and care of advanced ovarian cancer in the UK:results from the ADVOCATE study [PDF]

, 2013
Background:Most patients presenting with advanced ovarian cancer (AOC) eventually relapse. Symptom palliation, maintenance of quality of life (QoL) and prolongation of life are primary therapeutic goals.Methods:Sixty-six UK oncologists completed an ...
Monson, K, Susan Catt (4461673), S Banerjee (9892436), V Jenkins, I Solis-Trapala (7775843), I Solis-Trapala, C Gourley, A Montes (16163120), Jenkins, V, L Fallowfield, Montes, A, S Catt, K Monson, K Monson (13453767), Lesley Fallowfield (4461436), C Gourley (16163117), Valerie Jenkins (4460407), Gourley, C, S Banerjee, A Montes, Catt, S, Fallowfield, L, Banerjee, S, Solis-Trapala, I   +23 more
core   +1 more source

Hubungan Peritoneal Carcinomatosis Index dan Predictive Index Value Fagotti dengan Kadar Serum Fatty Acid Binding Protein 4 pada Kanker Ovarium Epitel Stadium Lanjut

Indonesian Journal of Cancer, 2017
In advanced ovarian cancer, the main goal of surgery is complete debulking with no visible residual tumor, and predicting it before surgery has become a goal that still unresolved.
MUHAMMAD RIZKI YAZNIL, BRAHMANA ASKANDAR TJOKROPRAWIRO, DYAH FAUZIAH   +2 more
doaj   +1 more source